A Study to Evaluate Single-dose of HB0043 in Healthy Adult Participants
Clinical trial NCT06999083 · COMPLETED
Trial details
- NCT number
- NCT06999083
- Sponsor
- Shanghai Huaota Biopharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-03
- Primary completion
- 2026-02-12
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.